List of articles in "Drug" category - Page 46

Budiodarone (ATI-2042) is an antiarrhythmic agent and chemical analog of amiodarone that is currently being studied in clinical trials. Amiodarone is considered the most effective antiarrhythmic drug available but its […]

Aceperone is a neuroleptic drug of the butyrophenone class. It is an α-noradrenergic blocking drug developed by Janssen Pharmaceutica in the 1960s.Because of its learning impairment effects in animals aceperone […]

Aceglatone (Glucaron) is an antineoplastic drug available in Japan.It is an inhibitor of the enzyme β-glucuronidase.

HybriCell is a therapeutic vaccine developed by Brazilian immunologist Jose Alexandre Barbuto. The treatment which inhibits the division of cancer cells is aimed at patients in later stages of kidney […]

Brivanib alaninate (INN/USAN) also known as BMS-582664 is an investigational anti-tumorigenic drug for oral administration. The drug is being developed by Bristol-Myers Squibb for the treatment of hepatocellular carcinoma or […]

Brexpiprazole (/brɛksˈpɪprəzoʊl/ breks-PIP-rə-zohl; also called OPC-34712) is a novel D2 dopamine partial agonist investigational product currently in clinical trials for the treatment of depression schizophrenia and attention deficit hyperactivity disorder […]

6-(2-Aminopropyl)indole (6-API 6-IT) is an indole derivative with no history of use in humans. The analogue 5-API is known to be psychoactive indicating 6-API may also be psychoactive by the […]

PF-00446687 is a drug developed by Pfizer for the treatment of erectile dysfunction which is a non-peptide agonist selective for the melanocortin receptor subtype MC4. It was found to be […]

O-774 is a classical cannabinoid derivative which acts as a potent agonist for the cannabinoid receptors with a Ki of 0.6 nM at CB1 and very potent cannabinoid effects in […]

AM-2389 is a classical cannabinoid derivative which acts as a potent and reasonably selective agonist for the CB1 receptor with a Ki of 0.16 nM and 26x selectivity over the […]